Publications by authors named "Sina Heider"

Article Synopsis
  • The CeTeG/NOA-09 trial found that combining CCNU with temozolomide significantly improved survival in newly diagnosed glioblastoma patients, increasing average survival from 31.4 months to 48.1 months.
  • A retrospective analysis of 70 patients receiving CCNU and temozolomide showed a median overall survival of 33.8 months and identified prolonged progression-free survival for those who also underwent TTFields treatment for at least eight weeks.
  • The study concluded that real-life outcomes for toxicity and survival are similar to the original trial, emphasizing that long-term TTFields therapy combined with CCNU and temozolomide is beneficial.
View Article and Find Full Text PDF

Medulloblastoma is the most frequent malignant brain tumor in children. During the last decades, the therapeutic landscape has changed significantly with craniospinal irradiation as the backbone of treatment. Survival times have increased and treatments were stratified according to clinical and later molecular risk factors.

View Article and Find Full Text PDF

Background: Peripheral sensory nerve injuries present a significant yet common challenge in acute hand trauma surgery. Standard treatment remains microsurgical end-to-end nerve repair where appropriate. Permanent loss of sensitivity and painful neuroma formation are typical sequelae of unsuccessful surgery.

View Article and Find Full Text PDF

Background: Complex peripheral nerve injuries of the hand include at least 300,000 cases per year in Europe. The standard treatment involves a microsurgical end-to-end suture of traumatic sensory nerve lesions of the hand without a gap. The objective of this study protocol is to evaluate whether the additional use of a chitosan nerve tube in primary repair of traumatic sensory nerve lesions of the hand without a gap has an effect on the recovery of sensitivity.

View Article and Find Full Text PDF